ESPEROVAX

Serial Number 88780321
606

Registration Progress

Application Filed
Jan 31, 2020
Under Examination
Jan 26, 2021
Approved for Publication
Dec 1, 2020
Published for Opposition
Dec 1, 2020
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ESPEROVAX
Previous Owner: Esperovax, Inc.
Classes: 005, 042

Trademark Image

ESPEROVAX

Basic Information

Serial Number
88780321
Filing Date
January 31, 2020
Published for Opposition
December 1, 2020
Abandonment Date
February 26, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 26, 2024
Classes
005 042

Rights Holder

Esperovax, Inc.

03
Address
46701 Commerce Center Dr.
Plymouth, MI 48170

Ownership History

Esperovax, Inc.

Original Applicant
03
Plymouth, MI

Esperovax, Inc.

Owner at Publication
03
Plymouth, MI

Legal Representation

Attorney
J. Matthew Buchanan

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

42 events
Date Code Type Description Documents
Feb 26, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Feb 26, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 4, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 3, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 25, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 3, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 25, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 21, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 19, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 19, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 19, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 14, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 12, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 12, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 12, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 7, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 27, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 25, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 25, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 25, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 15, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 13, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 13, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 13, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 8, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 8, 2021 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jul 8, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 8, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 26, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 1, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 1, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 11, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 22, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 21, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 21, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 21, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 22, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 22, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 22, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 21, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 5, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 4, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Vaccines; Oral vaccines; Modified cells for medical or clinical use; Pharmaceuticals in the nature of yeast-based pharmaceuticals; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for medical use
Class 042
Medical research in the field of vaccines and medicines; Research and development of vaccines and medicines; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the field of vaccines and medicines; Pharmaceutical research and development; Research and development in the field of immunology; Research and development in the field of microorganisms, namely, research and development related to yeast; Research and development in the field of therapeutics; Development of pharmaceutical preparations and medicines; Scientific study and research in the field of medicine; Scientific study and research in the field of healthcare products; Medical and scientific research; Discovery, development and design of pharmaceutical and therapeutic preparations; Pharmaceutical, biologic, and vaccine research and development

Classification

International Classes
005 042